New french TB study aims to improve treatment success

NCT ID NCT06893757

Recruiting now Knowledge-focused Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 2000 adults in France who are starting treatment for tuberculosis. Researchers will collect health data and samples like blood, urine, and breath over two years to see how well treatments work. The goal is to learn more about TB care and build a biobank for future studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could improve understanding of tuberculosis treatment outcomes in France and help develop better care strategies.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years and might not apply to other countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS

Contacts and locations

Locations

AP-HP Hôpital Saint Louis - Service des Maladies Infectieuses et Tropicales
NOT_YET_RECRUITING

Paris, 75010, France
Service de pneumologie et maladies infectieuses, Centre hospitalier Delafontaine
RECRUITING

Saint-Denis, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.